Follow the LIG아큐버 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, LIG아큐버 has logged 33 reports. Market capitalisation: €200bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: 엘아이지. The full history is openly available.
33
Insider Decl.
n/a
Thresholds
n/a
22 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LIG아큐버 Buy (bullish), based on 1 analysts. Average price target: ₩50,000.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,859 of 28,855 companies
22.3
score / 100
Value
18
Quality
26
FCF yld-5.1%
Earn yld-0.6%
EV/EBITDA44.7x
ROE·
Gross mgn24%
Net mgn-0.6%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
LIG아큐버 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative pharmaceutical solutions.